Posted 12 November, 2021
Bluejay Diagnostics, Inc. IPO completed
IPO completed detected for ticker Nasdaq:BJDX in a 424B4 filed on 12 November, 2021.
This is an initial public offering of units of our securities.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Bluejay Diagnostics, Inc.
Health Care/Life Sciences • Medical Equipment/Supplies
Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.Market Cap
$986K
View Company Details
$986K
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.